Biotechnica
Biotechnica is a UK-based manufacturer of seaweed extract biostimulants, microbial products, bioadjuvants, and soil conditioners, selling B2B direct to farmers, growers, and turf managers across agriculture, horticulture, animal feed, organics, and turf & amenity verticals; it operates as a subsidiary of Central Pharma from a Bedford production facility.
- Company typePrivate
- Founded1993
- HeadquartersBedford, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Biotechnica does
Biotechnica, operating under the legal name Central Pharma Biotechnica Ltd, is a UK-based manufacturer of biological agricultural inputs founded in 1993 and headquartered in Bedford, England, where it runs a consolidated production facility on the Elm Farm Industrial Estate. The company produces a portfolio built around Ascophyllum nodosum seaweed extracts, microbial products, bioadjuvants, and soil conditioners; its flagship AlgaFlex is a concentrated liquid seaweed extract containing a minimum of 30% w/v pure soluble seaweed solids, positioned as higher-concentration than most market alternatives. Supporting products include MyCortex and BactoLife DP104 (microbial products), BioFlow (bioadjuvant), and BiAmino AM3 and BioHumate (soil conditioners). The company self-identifies as the UK's largest manufacturer of seaweed extract and reports a 30% reduction in chemical fertilizer usage when AlgaFlex products are applied.
The company operates a B2B direct sales model targeting five end-market verticals: agriculture, horticulture, animal feed, organics, and turf & amenity (including prestigious sporting venues). Go-to-market is primarily domestic UK under Ex Works (Incoterms 2020) terms, supported by a content-led website with dedicated sector pages, a research articles library, corporate video, and direct expert consultation via phone and email. Revenue streams comprise branded product sales across all four product categories plus contract manufacturing services offered to third parties using Bedford-based production capacity. Pricing is quote-based and not publicly disclosed.
Biotechnica is a subsidiary of Central Pharma following acquisition and rebrand; current strategic activity includes partnerships with WWF UK's Seaweed Solutions Programme and the Co-op Foundation Carbon Innovation Fund (Norfolk Biostimulant Project), positioning the company within regenerative agriculture and ocean farming narratives. No revenue, funding, or headcount growth figures are disclosed, and there are no AI/ML or software-product components identified in the source data.
Biotechnica firmographics
Firmographics- Name
- Biotechnica
- Legal name
- Central Pharma Biotechnica Ltd
- Website
- https://biotechnica.co.uk
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Biotechnica is a UK-based manufacturer of seaweed extract biostimulants, microbial products, bioadjuvants, and soil conditioners, selling B2B direct to farmers, growers, and turf managers across agriculture, horticulture, animal feed, organics, and turf & amenity verticals; it operates as a subsidiary of Central Pharma from a Bedford production facility.
- Ownership category
- akta.pro rank
Biotechnica industry classification
Industry- Product category
- Agricultural Biostimulants and Biofertilizers
- NAICS
- Pesticide and Other Agricultural Chemical Manufacturing (32532), Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253)
- SIC
- Agricultural Chemicals (2870)
- akta.pro primary industry
- Biological Formulation, Fermentation & Scale-Up Manufacturing (AFABAEAM)
- akta.pro secondary industry
- Biorefinery Technology & Contract Processing (fractionation, tolling, scale-up) (IMAMALAL)
Keywords
Where Biotechnica is headquartered
LocationHeadquarters
- HQ city
- Bedford
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Biotechnica business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Seaweed Extract Products: Sale of concentrated liquid seaweed extract products (AlgaFlex) to agricultural, horticultural, and turf sectors for crop health, yield, and quality improvement.
- Microbial Products: Sale of microbial-based products (MyCortex, BactoLife DP104) for soil and plant health applications.
- BioAdjuvants: Sale of bioadjuvant products (BioFlow) for agricultural use.
- Soil Conditioners: Sale of soil conditioning products (BiAmino AM3, BioHumate) for soil health improvement.
- Contract Manufacturing: Contract manufacturing services offered to third parties, leveraging their manufacturing capabilities.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Biotechnica product offering
Product offeringCore offering
Biotechnica manufactures and sells concentrated liquid seaweed extract (AlgaFlex), microbial products (MyCortex, BactoLife DP104), a bioadjuvant (BioFlow), and amino acid- and humic acid-based soil conditioners (BiAmino AM3, BioHumate) for farmers, growers, and turf managers across the UK agriculture, horticulture, animal feed, organics, and turf & amenity sectors. The company also offers contract manufacturing services to third parties from its Bedford production facility and self-identifies as the UK's largest manufacturer of seaweed extract.
Product overview
Biotechnica is the UK's largest manufacturer of seaweed extract, offering a portfolio of biological agricultural products including seaweed extracts, microbial products, bioadjuvants, and soil conditioners. The core product AlgaFlex is a concentrated liquid seaweed extract with minimum 30% w/v soluble seaweed solids. The product line includes microbial solutions (MyCortex, BactoLife DP104), bioadjuvants (BioFlow), and soil conditioners (BiAmino AM3, BioHumate). The company also offers contract manufacturing services and serves sectors including agriculture, horticulture, animal feed, organics, and turf & amenity.
Differentiator
Problem solved
Functional benefit
Brands
- AlgaFlex: Concentrated liquid seaweed extract product containing minimum 30% w/v of pure soluble seaweed solids
- MyCortex
- BactoLife DP104
- BioFlow
- BiAmino AM3
- BioHumate
Products and services
- AlgaFlex Seaweed Extract Concentrated liquid seaweed extract containing a minimum of 30% w/v of pure soluble seaweed solids, used to increase crop health, yield, and quality. Sold to farmers, growers, and turf managers across the UK agriculture, horticulture, and turf & amenity sectors.
- MyCortex Microbial product designed to support plant growth and soil health for agricultural applications.
- BactoLife DP104 Microbial product formulation for agricultural applications supporting soil and plant health.
- BioFlow Bioadjuvant product designed to enhance the performance of agricultural applications.
- BiAmino AM3 Amino acid-based soil conditioner designed to improve soil structure and nutrient availability for agricultural use.
- BioHumate Humic acid-based soil conditioner for agricultural use to improve soil health.
- Contract Manufacturing Services Contract manufacturing services offered to third parties, leveraging Biotechnica's manufacturing capabilities from its Bedford, UK production facility.
Quantifiable outcome
- 30% reduction in chemical fertilizer usage
- +1 more outcomes
Companies that use Biotechnica
Customer profileSegments5 records
Ideal customer profiles5 records
Biotechnica technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Biotechnica partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- WWF UK (Seaweed Solutions Programme)corePartner in WWF UK's Seaweed Solutions Programme, working to understand and amplify the benefits of seaweed farming across the UK. Project focuses on regenerative ocean farming around UK coastlines.
- Central PharmacoreParent company - Central Pharma Biotechnica Ltd (company number 13182798). Central Pharma logo displayed in website footer indicating corporate partnership. Also partnered for manufacturing operations.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Biotechnica competitors and assessment
Company assessmentBroad incumbents
- ICL Group: ICL Group acquired Acadian Plant Health and is a global specialty fertilizers and biostimulants player; its plant-health division competes broadly with Biotechnica's seaweed extracts and crop-nutrition portfolio across multiple geographies.
- Valagro (Syngenta Biologicals): Valagro, now part of Syngenta Group, is a global leader in biostimulants and specialty crop nutrition with a portfolio overlapping Biotechnica's seaweed extract and microbial products, sold across agriculture and horticulture worldwide.
- Brandt: Brandt is a US-based specialty agricultural inputs manufacturer offering seaweed-based biostimulants, micronutrients, and adjuvants — overlapping with Biotechnica's product mix (seaweed extract, bioadjuvants, soil conditioners) for similar grower customers.
- Tradecorp: Tradecorp is a global manufacturer of biostimulants, specialty fertilizers, and crop nutrition products with a portfolio that overlaps Biotechnica's seaweed extracts and soil conditioners, particularly in horticulture and high-value crops.
- UPL: UPL is a global agrochemical company with an expanding biologicals portfolio through OpenAg, offering biostimulants and biosolutions that compete broadly with Biotechnica's regenerative-agriculture product range worldwide.
Direct peers
- Acadian Plant Health: Acadian Plant Health is one of the world's largest manufacturers of seaweed-based biostimulants and plant stress management products, directly competing with Biotechnica's AlgaFlex in the same crop-input category using similar Ascophyllum nodosum-based extracts.
- AlgaEnergy: AlgaEnergy is a Spain-based biotechnology company producing microalgae-based biostimulants and biofertilizers; while regionally focused in Southern Europe, it is a directly comparable specialist manufacturer of algae-derived agricultural inputs targeting similar customers and use cases as Biotechnica.
- BioAtlantis: BioAtlantis is an Ireland-based manufacturer of seaweed-derived biostimulants and crop health products, directly comparable to Biotechnica in product range, technology (Ascophyllum nodosum extracts), and target end-markets (agriculture and horticulture) in the British Isles.
- OMEX Agriculture: OMEX is a UK-based liquid fertilizer and biostimulant manufacturer selling into agriculture and horticulture, directly competing with Biotechnica in the British market with overlapping product categories and customer base.
Emerging players
- Koppert Biological Systems: Koppert is a global biological crop solutions provider with a growing biostimulant and microbial product range that overlaps with Biotechnica's MyCortex and BactoLife DP104 microbial offerings for sustainable agriculture.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Biotechnica social profiles
Digital presenceBiotechnica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biotechnica leadership team
Management profileNumber of profiles
Biotechnica funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biotechnica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biotechnica
What does Biotechnica do?
Biotechnica manufactures and sells concentrated liquid seaweed extract (AlgaFlex), microbial products (MyCortex, BactoLife DP104), a bioadjuvant (BioFlow), and amino acid- and humic acid-based soil conditioners (BiAmino AM3, BioHumate) for farmers, growers, and turf managers across the UK agriculture, horticulture, animal feed, organics, and turf & amenity sectors. The company also offers contract manufacturing services to third parties from its Bedford production facility and self-identifies as the UK's largest manufacturer of seaweed extract.
Is Biotechnica a public or private company?
Biotechnica is a private company. It is classified as corporate owned and is currently operating.
When was Biotechnica founded?
Biotechnica was founded in 1993. It employs 1 to 10 people.
Where is Biotechnica based?
Biotechnica is headquartered in Bedford, United Kingdom, in the Europe region.
How does Biotechnica make money?
Five revenue lines are on record. Seaweed Extract Products are the primary driver. The others are microbial Products, bioAdjuvants, soil Conditioners and contract Manufacturing.
Who are Biotechnica's main competitors?
Broad incumbents on record are ICL Group, Valagro (Syngenta Biologicals), Brandt, Tradecorp and UPL. Direct peers are Acadian Plant Health, AlgaEnergy, BioAtlantis and OMEX Agriculture. Koppert Biological Systems is listed as an emerging player.
Does Biotechnica have an API?
No public API is recorded for Biotechnica.
What industry is Biotechnica in?
Biotechnica's product category is Agricultural Biostimulants and Biofertilizers. Its primary akta.pro industry code is AFABAEAM, Biological Formulation, Fermentation & Scale-Up Manufacturing, with a secondary code of IMAMALAL, Biorefinery Technology & Contract Processing (fractionation, tolling, scale-up). Its NAICS code is 32532 and its SIC code is 2870.